{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:23:25Z","timestamp":1785356605509,"version":"3.55.0"},"reference-count":35,"publisher":"Wiley","issue":"5-6","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4011,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[1998,5]]},"abstract":"<jats:sec><jats:label\/><jats:p><jats:bold>Summary. <\/jats:bold> The Candida species isolated from oral rinses of 130 human immunodeficiency virus (HIV) infected patients were compared with those of 130 healthy non\u2010matched volunteers. The oral rinses were plated on CHROMagar Candida medium (CAC) and on CAC supplemented with 10 \u03bcg (CF10) and 100 \u03bcg (CF100) of fluconazoie per ml. The prevalence of non\u2010albicans Candida spp. in oral rinses of HIV\u2010infected patients and their correlation with the clinical and epidemiological characteristics of the patients were studied. Susceptibility of the Candida spp. isolated was determined by a microbroth dilution method based on the NCCLS reference procedure. Results of susceptibility tests of the yeast isolates were compared with their growth at the time of isolation on CAC supplemented with fluconazole. Thirty\u2010five (30.7%) strains of non\u2010albicans Candida spp. were isolated from the HIV\u2010positive population, vs. seven (15.9%) from the immunocompetent population. Growth on CF10 correlated in 96% of the cases with fluconazole minimum inhibitory concentration (MIC)&gt;8 \u03bc ml<jats:sup>\u20101<\/jats:sup>. Smoking and use of azoles were significantly associated with oral carriage of non\u2010albicans Candida spp. (P&lt;0.05). The prevalence of non\u2010albicans Candida spp. in HIV\u2010positive persons in oral rinse samples is twice as high as in the HIV\u2010negative population. Smoking and treatment with azoles are risk factors for the oral carriage of non\u2010albicans Candida spp. The isolation of yeasts on CAC plates supplemented with fluconazole allows combination of presumptive yeast identification and fluconazole susceptibility testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Zusammenfassung<\/jats:title><jats:p>Die Candida\u2010Isolate aus den Mundsp\u00fclproben von 130 HIV\u2010infizierten Personen wurden mit denen von 100 gesunden, unausgelesenen Freiwilligen verglichen. Die Mundsp\u00fclproben wurden auf CHROMagar Candida (CAC) und auf CAC mit 10 \u03bcg (CF10) und 100 \u03bcg (CF100) Fluconazol pro ml angelegt. Die H\u00e4ufigkeit von Nicht\u2010albicans Candida\u2010St\u00e4mmen in den Mundsp\u00fclproben der HIV\u2010Infizierten und ihre Korrelation mit den klinischen und epidemio\u2010logischen Besonderheiten der Patienten wurde erfa\u00dft. Die Empfindlichkeit der Candida\u2010Isolate wurde im Mikrodilutionstest gem\u00e4\u00df NCCLS\u2010Standard bestimmt. Die Ergebnisse der Empfind\u2010lichkeitspr\u00fcfung wurden mit ihrem Wachstum zum Zeitpunkt der Isolierung auf CAC mit Fluconazol\u2010Zusatz verglichen. In der HIV\u2010positiven Population wurden 35 Nicht\u2010albicans Candida\u2010St\u00e4mme (30.7%) gefunden gegen\u00fcber 7 St\u00e4mmen (15.9%) bei der immunkompetenten Vergleichsgruppe. Das Wachstum auf CFlO korrelierte in 96% der Falle mit der Fluconazol MHK &gt; 8 \u03bcg ml \u2010 <jats:sup>\u20101<\/jats:sup>. Rauchenund, 4zol\u2010Medikation waren signifikant mit oraler Besiedlung durch Xicht\u2010albicans Candida\u2010Arten assoziiert (P&lt; 0.05). Die Pravalenz von Nicht\u2010ulbicans Cundida\u2010Arten in Mundspulproben HIV\u2010positiver Personen war zweimal so hoch wie die in der HIV\u2010negativen Population. Rauchen und Azol\u2010Behandlung sind Risikofaktoren fur die orale Besiedlung mit Nicht\u2010ulbicans Candida\u2010Arten. Die Hefeisolierung auf CROMagar, supplementiert mit Fluconazol, erleichtert die Hefeidentifizierung und die Empfindlichkeitsprufung fur Fluconazol.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1439-0507.1998.tb00325.x","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T17:01:02Z","timestamp":1240592462000},"page":"203-211","source":"Crossref","is-referenced-by-count":30,"title":["Cross\u2010sectional study of oral Candida carriage in a human immunodeficiency virus (HIV)\u2010seropositive population: predisposing factors, epidemiology and antifungal susceptibility"],"prefix":"10.1111","volume":"41","author":[{"given":"Ann G.","family":"Schoofs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. C.","family":"Odds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Colebunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarethe","family":"Ieven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"issue":"71","key":"e_1_2_1_2_2","first-page":"11","article-title":"Fungal infections in AIDS patients.","volume":"44","author":"Stevens D. A.","year":"1991","journal-title":"Br. J. Clin. Pract."},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0924-8579(95)00049-6"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199406000-00010"},{"key":"e_1_2_1_5_2","first-page":"19","article-title":"Resistance trends in oral Candida infections: the clinical challenge","volume":"11","author":"Dupont B.","year":"1993","journal-title":"Clinician"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/jcm.34.7.1794-1797.1996","article-title":"Simple method for detecting fluconazole resistant yeasts with chromogenic agar.","volume":"34","author":"Patterson T. F.","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"e_1_2_1_7_2","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing for Years. Document M27. Villanova","author":"National Committee for Clinical Laboratory Standards","year":"1992"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/10454411940050020101"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01695634"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.9.2051"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.235"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(93)90064-B"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548709018473"},{"key":"e_1_2_1_14_2","first-page":"68","volume-title":"Candida and candidosis","author":"Odds F. C.","year":"1988"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198408093110602"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1991.tb00880.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1993.tb00043.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1989.tb01355.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(82)90280-8"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1984.tb01424.x"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(80)90147-8"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1991.tb00940.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1099\/13500872-141-7-1507"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.33.5.1129-1135.1995"},{"key":"e_1_2_1_25_2","first-page":"1129","article-title":"Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients with human immunodeficiency virus","volume":"33","author":"McCullough Ross B.","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1128\/jcm.31.8.2124-2133.1993","article-title":"Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency viruspositive and AIDS patients.","volume":"31","author":"Sullivan D.","year":"1993","journal-title":"J. Clin. Microbiol."},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.34.2.454-456.1996"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1128\/jcm.33.11.3025-3027.1995","article-title":"Use of CHROMagar Candida medium for isolation of yeasts from dental samples.","volume":"33","author":"Beighton D.","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02114896"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1128\/jcm.32.8.1923-1929.1994","article-title":"CHROMagar Candida, a new differential isolation medium for the presumptive identification of clinically important Candida species","volume":"32","author":"Odds F. C.","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/jcm.34.1.58-61.1996","article-title":"Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei and Candida glabrata.","volume":"34","author":"Pfaller M. A.","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.7.1530"},{"key":"e_1_2_1_33_2","first-page":"117","article-title":"Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS: a therapeutic approach","volume":"26","author":"Newman S. L.","year":"1994","journal-title":"J. Infect."},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.7.1512"},{"key":"e_1_2_1_35_2","first-page":"98","article-title":"Diversity among yeasts isolated from patients with AIDS and oral candidosis: focus on fluconazole susceptibility testing results","volume":"5","author":"Dellion S.","year":"1995","journal-title":"J. Mycol. M\u00e9d."},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/35.1.103"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.1998.tb00325.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.1998.tb00325.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T22:51:12Z","timestamp":1693608672000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.1998.tb00325.x"}},"subtitle":["Querschnittstudie \u00fcber orale Candida\u2010Besiedlung in der HIV\u2010seropositiven Bev\u00f6lkerung: Pr\u00e4dispositionsfaktoren, Epidemiologie und Antimyzetika\u2010Empfindlichkeit"],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":35,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1111\/j.1439-0507.1998.tb00325.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.1998.tb00325.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}